BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2013
View Archived Issues
Researchers from the University of California present two novel ROR1-targeting therapies
Read More
LY-2928057 dose-dependently increases serum iron levels in vivo
Read More
Moberg reports interim data from phase II study of MOB-015 for onychomycosis
Read More
BioLineRx reports initial phase II data for BL-8040 in AML
Read More
Millennium Pharmaceuticals begins phase I study of TAK-659
Read More
arGEN-X reports findings from dose-escalation part of phase Ib study of ARGX-110
Read More
Retrophin agrees to acquire Kyalin Biosciences
Read More
Evotec and Yale establish DNA repair research collaboration
Read More
Chimeric antigen receptor therapy for pediatric ALL targets the TSLPR
Read More
Novel BTK inhibitors patented by Pharmascience
Read More
Chinese researchers prepare new SGLT2 inhibitors for diabetes
Read More
Ares Trading presents novel BACE1 inhibitors for neurodegenerative disorders
Read More
Navidea Biopharmaceuticals submits supplemental NDA to FDA for Lymphoseek
Read More
Scientists at Phenex Pharmaceuticals disclose new ROR-gamma modulators
Read More
AnaptysBio forms antibody development agreement with Momenta Pharmaceuticals
Read More
Capricor Therapeutics cleared to begin phase II portion of ALLSTAR trial
Read More
Hoffmann-La Roche synthesizes new PDE10A inhibitors for psychotic disorders
Read More
Studies in different species reveal developmental role for Lhx6 in schizophrenia
Read More
Boehringer Ingelheim patents new GPR40 agonists for diabetes
Read More
New NPFF1 receptor antagonists for pain designed by French group
Read More
MultiStem receives orphan drug designation in Europe
Read More
Novel radioligand described for imaging Abeta in AD
Read More
FDA approves Prosigna breast cancer gene signature assay
Read More
Ixico offers business update
Read More
PIVKA-II test kit for HCC launched in Japan
Read More